Clinical Trials in Baltimore

Showing 1341-1360 of 20,142 trials

Peer Support for Liver Transplant Recipients With History of ALD

NCT07397598

Liver transplant (LT) recipients with a history of alcohol-related liver disease (ALD) may encounter various psychosocial and medical challenges during post-LT recovery, even beyond the initial post-transplant period. Effective and sustainable interventions will be crucial for improving patient outcomes. This clinical trial will examine the impact of peer support specialists (PSS) on the recovery experience of individuals who received LT for ALD. The trial seeks to answer two main questions: * Are LT recipients who work with PSS less likely to resume alcohol use or tend to drink less overall? * Do LT recipients who work with PSS engage more with recommended medical care and have better overall survival?

Alcohol Use DisorderAlcohol Related Liver DiseaseLiver Transplant Recipient

Johns Hopkins University95 participantsStarted May 2026

Baltimore, Maryland, United States

Active Not RecruitingPhase 2< 1 mile

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

NCT03607890

The purpose of this study is to evaluate the safety and clinical activity of nivolumab and relatlimab in patients with microsatellite instability high (MSI-H) solid tumors refractory to prior PD-(L)1 therapy.

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 TherapyMSI-H Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins38 participantsStarted Nov 2018

Los Angeles, California, United States • Baltimore, Maryland, United States

Peer Support for Liver Transplant Recipients With History of ALD

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

Find Trials by Condition in Baltimore

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Physiological Investigations of Movement Disorders

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

ELEVATE High-Risk PCI Pivotal Study

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Safety of RSV Preventive Monoclonal Antibody

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3